Efficacy and safety of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy

Efficacy and safety of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy

Background and aims. Patients with intrahepatic cholestasis of pregnancy (ICP) benefit from ursodeoxycholic acid (UDCA) treatment. Since there is still certain reluctance to use UDCA in pregnant women, mainly due to warnings in the official SPC information in respective drug leaflets, our objective...

Full description

Bibliographic Details
Main Authors: Antonin Parízek, Patrik Šimják, Andrej Cerný, Alena Šestinová, Anna Zdenková, Martin Hill, Michaela Dušková, Martin Procházka, Radovan Vlk, Zuzana Kokrdová, Michal Koucký, Libor Vitek
Format: Article
Language:English
Published: Elsevier 2016-09-01
Series:Annals of Hepatology
Subjects:
Drug safety
Fetal complications
Intrahepatic cholestasis of pregnancy
Pregnancy
Ursodeoxycholic acid
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119306398

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119306398

Similar Items